Waerlop 2023 (FLUCOP Consortium) reported results of two proficiency tests for cellular immune responses, influenza-specific IFN-ɣ ELISpot and ICS assays, organized to evaluate the impact of FLUCOP’s harmonization effort on assay results and the performance of participating FLUCOP partners.
Begue 2022 (FLUCOP Consortium) developed a harmonized consensus protocol for the ICS assay, which permits quantitative and qualitative evaluation of influenza vaccine-induced T-cell responses and may allow for future comparisons of T-cell responses to different next-generation influenza vaccine candidates. The harmonized ICS assay permits quantitative and qualitative evaluation of influenza vaccine-induced T-cell responses.
Waerlop 2022 (FLUCOP Consortium) described the harmonization and qualification of the influenza-specific IFN-ɣ ELISpot assay to detect and qualify vaccine-induced cellular immune responses.